Simon Y. K. Ong

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
5-Fluorouracil (5-FU) and its pro-drug Capecitabine have been widely used in treating colorectal cancer. However, not all patients will respond to the drug, hence there is a need to develop reliable early predictive biomarkers for 5-FU response. Here, we report a novel potentially functional Single Nucleotide Polymorphism (pfSNP) approach to identify SNPs(More)
  • 1